Авторы

  • Тожиддинов Х.С., Мусашайхова Ш.М.
  • Арипов О.А.
  • Бобоев К.Т.

Ключевые слова:

юрак ишемик касаллиги, SLC2A9, GLUT9, G/A полиморфизм, гиперурикемия, сийдик кислотаси, генетик хавф.

Библиографические ссылки

1. Khan M.A., Hashim M.J., Mustafa H. et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12:e9349.

2. Ralapanawa U., Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. J Epidemiol Glob Health. 2021;11(2):169–177.

3. Miyazawa K., Ito K. Genetic Analysis for Coronary Artery Disease Toward Diverse Populations. Front Genet. 2021;12:766485.

4. Wang H., Liu Z., Shao J. et al. Pathogenesis of premature coronary artery disease: Focus on risk factors and genetic variants. Genes & Diseases. 2020; 9(2):370–380.

5. Liu J., Yang W., Li Y. et al. ABCG2 rs22311 42 variant in hyperuricemia is modified by SLC2A9 polymorphisms and cardiovascular risk factors. BMC Medical Genetics. 2020; 21:1–9.

6. Lukkunaprasit T., Rattanasiri S., Turong-karavee S. et al. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis. BMC Medical Genetics. 2020;21(1):210.

7. Liu Y., Li Z., Xu Y. Uric acid and atherosclerosis: mechanisms and clinical implications. Kidney Diseases. 2025;11(1):112–127.

8. Medina-Leyte D.J., Zepeda-García O., Domínguez-Pérez M. et al. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021;22(8):3850.

9. Zhang M. et al. Triglyceride-glucose index and its additive interaction with ABCG2/SLC2A9 polygenic risk score on hyperuricemia in middle age and older adults: findings from the DLCC and BHMC study. Annals of Medicine. 2024;56(1):24–31.